Synthesis and antitumor activities of a series of novel quinoxalinhydrazides

Bioorganic and Medicinal Chemistry

Volumn 15, Issue 1, 2007, Pages 288-294

  Grande, Fedora ^a,b   Aiello, Francesca ^a,b   Grazia, Osvaldo De ^a   Brizzi, Antonella ^c   Garofalo, Antonio ^a   Neamati, Nouri ^b  

^a UNIVERSITY OF CALABRIA   (Italy)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1H INDOLE 2 CARBOXYLIC ACID N' PYRROLO[1,2 A]QUINOXALIN 4 YLHYDRAZIDE; 1H INDOLE 3 CARBOXYLIC ACID N' PYRROLO[1,2 A]QUINOXALIN 4 YLHYDRAZIDE; 1H INDOLE 5 CARBOXYLIC ACID N' PYRROLO[1,2 A]QUINOXALIN 4 YLHYDRAZIDE; 1H INDOLE 6 CARBOXYLIC ACID N' PYRROLO[1,2 A]QUINOXALIN 4 YLHYDRAZIDE; 2 METHOXY N' (H PYRROLO[1,2 A]QUINOXALIN 4 YL)BENZOHYDRAZIDE; 3 AMINOPROPIONIC ACID N' PYRROLO[1,2 A]QUINOXALIN 4 YLHYDRAZIDE; ANTINEOPLASTIC AGENT; HYDRAZIDE DERIVATIVE; N' (7 FLUOROPYRROLO[1,2 A]QUINOXALIN 4 YL) 2' FLUOROBENZOYLHYDRAZIDE; N' (7 FLUOROPYRROLO[1,2 A]QUINOXALIN 4 YL)FURAN 2 CARBOHYDRAZIDE; N' (7 FLUOROPYRROLO[1,2 A]QUINOXALIN 4 YL)NICOTINYLHYDRAZIDE; N' (7 FLUOROPYRROLO[1,2 A]QUINOXALIN 4 YL)PYRAZINE 2 CARBOHYDRAZIDE; N' (7 FLUOROPYRROLO[1,2 A]QUINOXALIN 4 YL)PYRIDINE 2 CARBOHYDRAZIDE; N' (7 FLUOROPYRROLO[1,2 A]QUINOXALIN 4 YL)QUINOXALINE 2 CARBOHYDRAZIDE; N' (7 FLUOROPYRROLO[1,2 A]QUINOXALIN 4 YL)THIOPHENE 2 CARBOHYDRAZIDE; N' (9 FLUOROPYRROLO[1,2 A]QUINOXALIN 4 YL)PYRAZINE 2 CARBOHYDRAZIDE; QUINOXALINE DERIVATIVE; SC 144; SC 153; SC 154; SC 155; SC 156; SC 157; SC 158; SC 159; SC 160; SC 161; SC 162; SC 163; SC 164; SC 165; SC 166; THIAZOLIDINE 4 CARBOXYLIC ACID N' PYRROLO[1,2 A]QUINOXALIN 4 YLHYDRAZIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CHEMICAL MODIFICATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; HYDRAZINES; MOLECULAR STRUCTURE; QUINOXALINES; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33751085637     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2006.09.073     Document Type: Article

References (10)

1. Neamati N., and Barchi Jr. J.J. Curr. Top. Med. Chem. 2 (2002) 211-227
2. Lipinski C.A. J. Pharmacol. Toxicol. Methods 44 (2000) 235-249
3. Lipinski C.A., Lombardo F., Dominy B.W., and Feeney P.J. Adv. Drug Deliv. Rev. 23 (1997) 3-25
4. Plasencia C., Dayam R., Wang Q., Pinski J., Burke Jr. T.R., Quinn D.I., and Neamati N. Mol. Cancer Ther. 4 (2005) 1105-1113
5. Melek M., Jones J.M., O'Dea M.H., Pais G., Burke Jr. T.R., Pommier Y., Neamati N., and Gellert M. Proc. Natl. Acad. Sci. U.S.A 99 (2002) 134-137
6. Plasencia, C.; Grande, F.; Oshima, T.; Sanchez, T.; Aiello, F.; Garofalo, A.; Neamati, N. J. Med. Chem. 2006, under review.
7. Reich M.F., Fabio P.F., Lee V.J., Kuck N.A., and Testa R.T. J. Med. Chem. 32 (1989) 2474-2478
8. Fand T.I., and Spoerri P.E. J. Am. Chem. Soc. 74 (1952) 1345
9. Carmichael J., DeGraff W.G., Gazdar A.F., Minna J.D., and Mitchell J.B. Cancer Res. 47 (1987) 936-942
10. Munshi A., Hobbs M., and Meyn R.E. Methods Mol. Med. 110 (2005) 21-28